Dexmedetomidine Hydrochloride Injection
Product Images NDC 25021-617

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dexmedetomidine Hydrochloride (NDC 25021-617). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Dex21 0000 01)

Structural Formula (Dex21 0000 01)
Chemical structure of Dexmedetomidine Hydrochloride showing its molecular arrangement including imidazole and aromatic rings with hydrochloride component.*
FDA Label Image

Package Label – Principal Display Panel – Bag Label (Dex21 0000 02)

Package Label – Principal Display Panel – Bag Label (Dex21 0000 02)
Label for Dexmedetomidine Hydrochloride injection, 4 mcg/mL (400 mcg per 100 mL), in 0.9% Sodium Chloride Injection, provided as a 100 mL single-dose flexible container. Manufactured by Sagent Pharmaceuticals. Label indicates intravenous infusion use only, ready to use without dilution, with storage and usage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.